Joint Formulary & PAD

Carbamazepine - Bipolar disorder (adults)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Modified release tablets
  • Oral suspension
  • Tablets
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Carbamazepine
Indication :
Bipolar disorder (adults)
Group Name :
Keywords :
Brand Names Include :
Important Information :

For use in patients who are unresponsive to lithium.

Initiation and stabilisation by the mental health specialist for at least 1 month before any request for transfer of care to primary care.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Carbamazepine is used to treat.